Snyder, A., Allen, P., Shamseddine, A., Haydar, A., Eloubeidi, M., Faraj, W., … O’Reilly, E. M. (2012). Neoadjuvant therapy in clinical stage II pancreatic adenocarcinoma. Gastrointestinal Cancer Research, 5(5), 169–173.

Snyder, A., P. Allen, A. Shamseddine, A. Haydar, M. Eloubeidi, W. Faraj, M. Khalife, et al. “Neoadjuvant therapy in clinical stage II pancreatic adenocarcinoma.” Gastrointestinal Cancer Research 5, no. 5 (September 1, 2012): 169–73.

Snyder A, Allen P, Shamseddine A, Haydar A, Eloubeidi M, Faraj W, et al. Neoadjuvant therapy in clinical stage II pancreatic adenocarcinoma. Gastrointestinal Cancer Research. 2012 Sep 1;5(5):169–73.

Snyder, A., et al. “Neoadjuvant therapy in clinical stage II pancreatic adenocarcinoma.” Gastrointestinal Cancer Research, vol. 5, no. 5, Sept. 2012, pp. 169–73.

Snyder A, Allen P, Shamseddine A, Haydar A, Eloubeidi M, Faraj W, Khalife M, Temraz S, El-Olayan A, Kelsen DP, El-Merhi F, Naghy M, Saltz LB, Abou-Alfa GK, O’Reilly EM. Neoadjuvant therapy in clinical stage II pancreatic adenocarcinoma. Gastrointestinal Cancer Research. 2012 Sep 1;5(5):169–173.